FDA Inspection 1008026 — Hunterdon Medical Center Blood Bank
The FDA completed an inspection of Hunterdon Medical Center Blood Bank on April 5, 2017 in Flemington, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 5, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Flemington, NJ (United States)